CA2220837A1 - Compositions of interleukin and pyrimidine nucleosides - Google Patents

Compositions of interleukin and pyrimidine nucleosides Download PDF

Info

Publication number
CA2220837A1
CA2220837A1 CA002220837A CA2220837A CA2220837A1 CA 2220837 A1 CA2220837 A1 CA 2220837A1 CA 002220837 A CA002220837 A CA 002220837A CA 2220837 A CA2220837 A CA 2220837A CA 2220837 A1 CA2220837 A1 CA 2220837A1
Authority
CA
Canada
Prior art keywords
deoxy
cytidine
fluoro
fluorocytidine
pyrimidine nucleoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002220837A
Other languages
English (en)
French (fr)
Inventor
Kazushige Mori
Yutaka Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2220837A1 publication Critical patent/CA2220837A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002220837A 1995-05-26 1996-05-15 Compositions of interleukin and pyrimidine nucleosides Abandoned CA2220837A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95108063.9 1995-05-26
EP95108063 1995-05-26

Publications (1)

Publication Number Publication Date
CA2220837A1 true CA2220837A1 (en) 1996-11-28

Family

ID=8219298

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002220837A Abandoned CA2220837A1 (en) 1995-05-26 1996-05-15 Compositions of interleukin and pyrimidine nucleosides

Country Status (9)

Country Link
EP (1) EP0828508A2 (zh)
JP (1) JPH10506641A (zh)
CN (1) CN1184430A (zh)
AR (1) AR005417A1 (zh)
AU (1) AU5998296A (zh)
BR (1) BR9608779A (zh)
CA (1) CA2220837A1 (zh)
TR (1) TR199701435T1 (zh)
WO (1) WO1996037214A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives

Also Published As

Publication number Publication date
JPH10506641A (ja) 1998-06-30
CN1184430A (zh) 1998-06-10
AU5998296A (en) 1996-12-11
WO1996037214A2 (en) 1996-11-28
TR199701435T1 (xx) 1998-03-21
MX9708915A (es) 1998-03-31
BR9608779A (pt) 1999-07-06
WO1996037214A3 (en) 1997-01-09
EP0828508A2 (en) 1998-03-18
AR005417A1 (es) 1999-06-23

Similar Documents

Publication Publication Date Title
JP2590248B2 (ja) 抗ウイルス・抗腫瘍・抗転移・免疫系増強ヌクレオシド類およびヌクレオチド類
US6344447B2 (en) Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5736531A (en) Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
CA2111571C (en) Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
AU2486088A (en) Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides
WO1994026761A1 (en) Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
IL112373A (en) Use of interleukin-12 for the preparation of a pharmaceutical composition for preventing, ameliorating and treating graft-versus-host disease
KR100418483B1 (ko) 조혈 개선을 위한 비이온 계면 활성제를 포함하는 조성물 및 이를 이용한 치료방법
JPS6036420A (ja) ヒトのがん細胞に対するヒト腫瘍壊死因子およびヒト・インタ−フエロンの作用および方法
JPH10507441A (ja) オキシプリンヌクレオシドを用いる敗血症または炎症性疾患の処置方法
EP0231819B1 (en) Pharmaceutical agent for the treatment of myelogenous leukemia
EP0488718B1 (en) Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
AU732120B2 (en) Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
Burchenal et al. Activity of 2-Fluoro-5-methylarabinofuranosyluracil against Mouse Leukemias Sensitive to and Resistant to 1-β-d-Arabinofuranosylcytosine
US6267968B1 (en) MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
CA2220837A1 (en) Compositions of interleukin and pyrimidine nucleosides
US4997645A (en) Methods and pharmaceutical composition for the treatment of tumors
MXPA97008915A (en) Compositions of interleucine and nucleosides of pirimid
CA1316830C (en) Agent for treating or preventing thrombocytopenia
CA2323791A1 (en) Purine l-nucleosides, analogs and uses thereof
KR20100131457A (ko) 시티딘 유도체 및 카르보플라틴을 함유하는 항종양제
CA2322053A1 (en) Novel nucleosides

Legal Events

Date Code Title Description
FZDE Dead